. Author manuscript; available in PMC: 2020 Aug 1.

Published in final edited form as: Arterioscler Thromb Vasc Biol. 2019 Jul 11;39(8):1565–1573. doi: 10.1161/ATVBAHA.119.313011

Table 1:

Descriptive characteristics of fold-change time-courses for lymph flow, triglyceride (TG) concentration, and TG output following administration of the treatments at 300mins

	Placebo	GLC	GLP-2	GLP-2 + GLC	SEM	P-value
Lymph flow
Time to peak (min)	28.8^ab	32.7^ab	14.6^b	35.1^a	5.50	0.023
Maximal fold change	1.39^b	2.44^ab	2.68^a	2.73^ab	0.38	0.033
Slope of rise (fold change/hr)	1.45	3.93	6.54	5.01	1.67	0.125
Slope of decline (fold change/hr)	−1.24	−2.21	−1.43	−1.31	0.49	0.334
Fold change at 60 minutes	1.15^b	1.18^b	1.68^ab	2.03^a	0.20	0.009
Cumulative lymph volume at 60 minutes (ml)	2.72^b	3.27^ab	4.40^a	4.23^a	0.39	0.002
Triglyceride concentration
Time to peak (min)	19.4	12.0	9.46	11.45	3.26	0.169
Maximal fold change	0.98^b	2.21^a	1.19^ab	1.76^ab	0.29	0.019
Slope of rise (fold change/hr)	1.45	5.64	1.91	4.29	1.86	0.228
Slope of decline (fold change/hr)	−0.94^b	−2.77^a	−1.32^ab	−2.22^ab	0.44	0.018
Fold change at 60 minutes	0.75	0.60	0.62	0.49	0.08	0.131
Cumulative TG mass at 60 minutes (mg)	129	230	239	228	35.8	0.058
TG output
Time to peak (min)	19.9	22.9	13.9	18.4	3.87	0.435
Maximal fold change	1.18^b	3.05^a	2.67^ab	3.17^a	0.48	0.021
Slope of rise (fold change/hr)	1.21^b	8.07^a	6.55^ab	10.4^a	2.59	0.049
Slope of decline (fold change/hr)	−0.67^b	−3.87^a	−2.14^ab	−3.30^a	0.64	0.005
Fold change at 60 minutes	0.778	0.753	0.973	0.979	0.15	0.260

^a,b

Superscripts of differing letters within a row indicate significant differences as identified by Tukey separation